Detailed information for compound 911628

Basic information

Technical information
  • TDR Targets ID: 911628
  • Name: N-[5-(4-bromophenyl)-1,3,4-thiadiazol-2-yl]-3 -(trifluoromethyl)benzamide
  • MW: 428.226 | Formula: C16H9BrF3N3OS
  • H donors: 1 H acceptors: 3 LogP: 4.77 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: Brc1ccc(cc1)c1nnc(s1)NC(=O)c1cccc(c1)C(F)(F)F
  • InChi: 1S/C16H9BrF3N3OS/c17-12-6-4-9(5-7-12)14-22-23-15(25-14)21-13(24)10-2-1-3-11(8-10)16(18,19)20/h1-8H,(H,21,23,24)
  • InChiKey: ITJHHKWHXPBTCK-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • EU-0070634

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Loa Loa (eye worm) CMGC/GSK protein kinase 0.0052 0.33 0.3019
Schistosoma mansoni glycogen synthase kinase 3-related (gsk3) (cmgc group III) 0.0052 0.33 0.4528
Giardia lamblia Kinase, CMGC GSK 0.0052 0.33 0.7121
Trichomonas vaginalis CMGC family protein kinase 0.0052 0.33 0.7121
Entamoeba histolytica protein kinase, putative 0.0052 0.33 0.7121
Loa Loa (eye worm) hypothetical protein 0.0053 0.3385 0.3107
Echinococcus granulosus glutaminyl tRNA synthetase 0.0091 0.6801 1
Trichomonas vaginalis glutaminyl-tRNA synthetase, putative 0.0065 0.4472 1
Schistosoma mansoni glutaminyl-tRNA synthetase (glutamine--tRNA ligase) (glnrs) 0.0091 0.6801 1
Echinococcus multilocularis glutaminyl tRNA synthetase 0.0091 0.6801 1
Leishmania major glutaminyl-tRNA synthetase, putative 0.0029 0.1272 0.3
Trypanosoma cruzi glycogen synthase kinase 3, putative 0.0052 0.33 1
Leishmania major glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 0.0052 0.33 1
Plasmodium falciparum glycogen synthase kinase 3 0.0052 0.33 1
Echinococcus granulosus protein kinase shaggy 0.0052 0.33 0.4528
Trypanosoma cruzi asparaginyl-tRNA synthetase, putative 0.0036 0.1932 0.5275
Loa Loa (eye worm) glutaminyl-tRNA synthetase 0.0128 1 1
Plasmodium falciparum glutamine--tRNA ligase, putative 0.0029 0.1272 0.3
Giardia lamblia Kinase, CMGC GSK 0.0052 0.33 0.7121
Trypanosoma brucei protein kinase, putative 0.0052 0.33 1
Echinococcus multilocularis glycogen synthase kinase 3 beta 0.0052 0.33 0.4528
Toxoplasma gondii glutaminyl-tRNA synthetase (GlnRS) 0.0029 0.1272 0.3855
Trypanosoma cruzi glutaminyl-tRNA synthetase, putative 0.0029 0.1272 0.3
Giardia lamblia Glutaminyl-tRNA synthetase 0.0065 0.4472 1
Echinococcus multilocularis protein kinase shaggy 0.0052 0.33 0.4528
Plasmodium vivax glycogen synthase kinase 3, putative 0.0052 0.33 1
Entamoeba histolytica protein kinase domain containing protein 0.0052 0.33 0.7121
Echinococcus granulosus glycogen synthase kinase 3 beta 0.0052 0.33 0.4528
Entamoeba histolytica protein kinase domain containing protein 0.0052 0.33 0.7121
Trypanosoma brucei glutaminyl-tRNA synthetase, putative 0.0029 0.1272 0.3
Trypanosoma brucei asparaginyl-tRNA synthetase, putative 0.0036 0.1932 0.5275
Onchocerca volvulus 0.0052 0.33 1
Trichomonas vaginalis CMGC family protein kinase 0.0052 0.33 0.7121
Toxoplasma gondii cell-cycle-associated protein kinase GSK, putative 0.0052 0.33 1
Loa Loa (eye worm) CMGC/GSK protein kinase 0.0052 0.33 0.3019
Leishmania major asparaginyl-tRNA synthetase, putative 0.0036 0.1932 0.5275
Brugia malayi intracellular kinase 0.0052 0.33 0.3019
Entamoeba histolytica glutaminyl-tRNA synthetase, putative 0.0065 0.4472 1

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.